Amgen Inc. (AMGN) Shareholders’ equity 2016–2025
Amgen Inc. (AMGN) shareholders’ equity at each fiscal year-end, per SEC filings.
$8.7BFY2025 · since FY2016: $29.9B → $8.7B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $8.7B | +47.3% |
| FY2024 | $5.9B | -5.7% |
| FY2023 | $6.2B | +70.2% |
| FY2022 | $3.7B | -45.4% |
| FY2021 | $6.7B | -28.8% |
| FY2020 | $9.4B | -2.7% |
| FY2019 | $9.7B | -22.6% |
| FY2018 | $12.5B | -50.5% |
| FY2017 | $25.2B | -15.5% |
| FY2016 | $29.9B | — |
Source: SEC XBRL filings · For reference only · Not investment advice